Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beta Bionics, Inc.(BBNX) | 2,500 | 281,250 | +278,750 | $6.25M | $5.59M | 34.05% | -$659.5K |
| Insight Molecular Diagnostics Inc.(IMDX) | 18,700 | 947,134 | +928,434 | $2.86M | $3.14M | 19.16% | +$284.1K |
| Caris Life Sciences, Inc.(CAI) | 45,000 | 89,940 | +44,940 | $2.40M | $2.72M | 16.58% | +$317.5K |
| Establishment Labs Holdings Inc.(ESTA) | 89,940 | 45,000 | -44,940 | $1.92M | $1.84M | 11.24% | -$77.4K |
| InspireMD, Inc.(NSPR) | 450,517 | 450,517 | 0 | $1.02M | $1.09M | 6.62% | +$63.1K |
| Outset Medical, Inc.(OM) | 429,120 | 5,000 | -424,120 | $1.36M | $1.00M | 6.09% | -$360.5K |
| Metagenomi Therapeutics, Inc.(MGX) | 952,134 | 264,391 | -687,743 | $391.3K | $626.6K | 3.82% | +$235.3K |
| Natera, Inc.(NTRA) | 245,691 | 2,500 | -243,191 | $422.4K | $402.4K | 2.45% | -$19.9K |